Preventing acute decrease in renal function induced by coronary angiography (PRECORD): a prospective randomized trial.

[1]  Richard Solomon,et al.  Contrast-induced acute kidney injury. , 2010, Circulation.

[2]  C. Becker,et al.  Strategies to reduce the risk of contrast-induced nephropathy. , 2006, The American journal of cardiology.

[3]  R. Bersin,et al.  Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial. , 2004, JAMA.

[4]  Kirk N. Garratt,et al.  Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention , 2002, Circulation.

[5]  Ethan M Balk,et al.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  S. Marsch,et al.  Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. , 2002, Archives of internal medicine.

[7]  Samin K. Sharma,et al.  A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: Effect of selective dopamine receptor agonist fenoldopam , 2002, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  A. Serra,et al.  Prophylactic hemodialysis after radiocontrast media in patients with renal insufficiency is potentially harmful. , 2001, The American journal of medicine.

[9]  L. Ruilope,et al.  Renal function: the Cinderella of cardiovascular risk profile. , 2001, Journal of the American College of Cardiology.

[10]  W. Aronow,et al.  Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. , 2000, The American journal of cardiology.

[11]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[12]  W Zidek,et al.  Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. , 2000, The New England journal of medicine.

[13]  W. O’Neill,et al.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy ☆: Results of the P.R.I.N.C.E. study , 1999 .

[14]  Allen J. Taylor,et al.  Clinical InvestigationsCardiologyPREPARED: PREParation for Angiography in REnal Dysfunction: A Randomized Trial of Inpatient vs Outpatient Hydration Protocols for Cardiac Catheterization in Mild-to-Moderate Renal Dysfunction , 1998 .

[15]  R. Stack,et al.  Progression of renal artery stenosis in patients undergoing cardiac catheterization. , 1998, American heart journal.

[16]  E. Bates,et al.  Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[17]  S. Morcos.  Contrast media-induced nephrotoxicity--questions and answers. , 1998, The British journal of radiology.

[18]  W. O’Neill,et al.  Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. , 1997, The American journal of medicine.

[19]  W. O’Neill,et al.  A randomized trial of low osmolar ionic versus nonionic contrast media in patients with myocardial infarction or unstable angina undergoing percutaneous transluminal coronary angioplasty. , 1996, Journal of the American College of Cardiology.

[20]  N. Sinha,et al.  Use of dopamine in prevention of contrast induced acute renal failure--a randomised study. , 1996, International journal of cardiology.

[21]  J. D'Elia,et al.  Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents. , 1994, The New England journal of medicine.

[22]  M. Rudnick,et al.  Nephrotoxic risks of renal angiography: contrast media-associated nephrotoxicity and atheroembolism--a critical review. , 1994, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[23]  P. Huppert,et al.  Adenosine antagonist theophylline prevents the reduction of glomerular filtration rate after contrast media application. , 1994, Kidney international.

[24]  S. Ellahham,et al.  Cholesterol embolism: an underdiagnosed clinical entity. , 1992, American heart journal.

[25]  L. Smith,et al.  Renal artery stenosis: prevalence and associated risk factors in patients undergoing routine cardiac catheterization. , 1992, Journal of the American Society of Nephrology : JASN.

[26]  M. Rich,et al.  Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. , 1990, Archives of internal medicine.

[27]  P. Parfrey,et al.  Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. , 1989, The New England journal of medicine.

[28]  M. Hlatky,et al.  Contrast nephrotoxicity: a randomized controlled trial of a nonionic and an ionic radiographic contrast agent. , 1989, The New England journal of medicine.

[29]  G. Verpooten,et al.  INTERPRETATION OF CREATININE CLEARANCE , 1987, The Lancet.

[30]  F. Giron,et al.  Renal dysfunction after arteriography. , 1985, JAMA.

[31]  A. Gomes,et al.  Risk of renal failure after major angiography. , 1983, Archives of surgery.

[32]  J. Cohen,et al.  Hospital-acquired renal insufficiency: a prospective study. , 1983, The American journal of medicine.

[33]  W. Bank,et al.  Renal failure after major angiography can be avoided with hydration. , 1981, AJR. American journal of roentgenology.

[34]  M. H. Gault,et al.  Prediction of creatinine clearance from serum creatinine. , 1975, Nephron.

[35]  W. Sniper.  TERMINAL FITTINGS FOR MEDICAL GAS PIPELINES , 1975, The Lancet.

[36]  Kdoqi Disclaimer.  K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[37]  W. O’Neill,et al.  A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation. , 1999, Journal of the American College of Cardiology.

[38]  P. Kurnik,et al.  Risk of radiocontrast nephropathy in patients with and without diabetes mellitus. , 1994, Kidney international.